Great Basin secures additional $9.5 million in funding

This is an archived article that was published on in 2013, and information in the article may be outdated. It is provided only for personal research purposes and may not be reprinted.

Great Basin Corp., a privately held West Valley City-based company that is developing simple-to-use molecular diagnostic test, said it has received $9.5 million in additional capital.

The funding was provided by the previous investors in the company, Great Basin said. It will be used to expand manufacturing, fund research and develop additional products.

Great Basin received clearance from the U.S. Food and Drug Administration in May to market its first product, a molecular diagnostic test for toxigenic Colstridium difficlie — one of the most common and deadly hospital-acquired infections.